A Randomized Phase II Study of Nivolumab Plus Ipilimumab Versus Standard of Care in Previously Untreated and Advanced Non-Clear Cell Renal Cell Carcinoma (Suniforecast)

Ahrens M, Escudier B, Boleti E, Grimm MO, Goupir MG, Barthelemy P, Gravis G, Bedekes J, Ivanyi P, Panic A, Zschaebitz S, Neyrieru S, Mellado B, Biel A, Wadell T, Pablo Maroto J, Retz M, Boegemann M, Rottey S, Haanen J, Oosting S, Castellano D, Hartmann A, Bergmann L (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Publisher: KARGER

City/Town: BASEL

Pages Range: 226-226

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

DOI: 10.1200/jco.2020.38.15_suppl.tps5103

Authors with CRIS profile

Involved external institutions

Universitätsklinikum Frankfurt am Main (KGU) Germany (DE) Universitätsklinikum Düsseldorf Germany (DE) University of Manchester United Kingdom (GB) University Medical Center Groningen (UMCG) / Universitair Medisch Centrum Groningen Netherlands (NL) Klinikum rechts der Isar Germany (DE) Universitätsklinikum Münster Germany (DE) Universitätsklinikum Essen Germany (DE) Centre Léon-Bérard (UNICANCER) France (FR) Universitätsklinikum Heidelberg Germany (DE) University College London (UCL) United Kingdom (GB) Netherlands Cancer Institute (NKI) Netherlands (NL) Centre Hospitalier Universitaire de Bordeaux / CHU Bordeaux France (FR) Medizinische Hochschule Hannover (MHH) / Hannover Medical School Germany (DE) University Hospital Ghent Belgium (BE) Universitätsklinikum Jena Germany (DE) Institut Gustave-Roussy France (FR) Hospital de la Santa Creu i Sant Pau Spain (ES) Hôpitaux universitaires de Strasbourg (HUS) / University Hospital Strasbourg France (FR) Universitätsklinikum Tübingen Germany (DE) Institute Paoli-Calmettes France (FR) Hospital Clínic de Barcelona Spain (ES)

How to cite

APA:

Ahrens, M., Escudier, B., Boleti, E., Grimm, M.-O., Goupir, M.G., Barthelemy, P.,... Bergmann, L. (2020). A Randomized Phase II Study of Nivolumab Plus Ipilimumab Versus Standard of Care in Previously Untreated and Advanced Non-Clear Cell Renal Cell Carcinoma (Suniforecast). In ONCOLOGY RESEARCH AND TREATMENT (pp. 226-226). BASEL: KARGER.

MLA:

Ahrens, Marit, et al. "A Randomized Phase II Study of Nivolumab Plus Ipilimumab Versus Standard of Care in Previously Untreated and Advanced Non-Clear Cell Renal Cell Carcinoma (Suniforecast)." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2020. 226-226.

BibTeX: Download